scholarly article | Q13442814 |
P356 | DOI | 10.1002/JPS.2600650330 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0022354915406586?httpAccept=text/xml |
https://api.elsevier.com/content/article/PII:S0022354915406586?httpAccept=text/plain | ||
P698 | PubMed publication ID | 1263097 |
P2093 | author name string | R. G. McAllister | |
S. M. Howell | |||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | verapamil | Q410291 |
pharmaceutical science | Q7180763 | ||
P304 | page(s) | 431-432 | |
P577 | publication date | 1976-03-01 | |
P1433 | published in | Journal of Pharmaceutical Sciences | Q3186933 |
P1476 | title | Fluorometric assay of verapamil in biological fluids and tissues | |
Fluorometric Assay of Verapamil in Biological Fluids and Tissues | |||
P478 | volume | 65 |
Q79745004 | A common method for the determination of several calcium channel blockers using an HPLC system with ultraviolet detection |
Q72925190 | Absence of slow channel-dependent conduction within the His-Purkinje (bundle branch) reentrant circuit: A clinical and experimental study of the effects of verapamil |
Q71242375 | Analysis of verapamil in plasma by liquid chromatography |
Q41741431 | Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat |
Q39373749 | Beneficial myocardial metabolic effects of insulin during verapamil toxicity in the anesthetized canine |
Q40146301 | Calcium Antagonists Pharmacokinetic Properties |
Q40146304 | Calcium antagonists. Clinical use in the treatment of arrhythmias |
Q40167931 | Clinical Pharmacokinetics of Verapamil |
Q70478662 | Clinical pharmacokinetics of verapamil in patients with atrial fibrillation |
Q41606809 | Decreased uptake of 5-hydroxytryptamine and dopamine into blood platelets from depressed patients [proceedings] |
Q44199634 | Determination of verapamil by adsorptive stripping voltammetry in urine and pharmaceutical formulations |
Q43781109 | Determination of verapamil in pharmaceutical formulations using atomic emission spectrometry |
Q35885320 | Effect of verapamil on blood pressure and lesions in heart and kidney of rats made hypertensive by deoxycorticosterone (DOC). |
Q33821933 | Effects of verapamil on ventricular tachycardias possibly caused by reentry, automaticity, and triggered activity |
Q72671407 | Electropharmacology of the Slow-Channel Inhihitors in the Management of Cardiac Arrhythmias: Verapamil |
Q41507555 | GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration |
Q70879017 | High-performance liquid chromatographic determination of verapamil in plasma by fluorescence detection |
Q39529940 | Kinetic Spectrofluorometric Determination of Certain Calcium Channel Blockers via Oxidation with Cerium (IV) in Pharmaceutical Preparations |
Q58130404 | Quantitation of Verapamil and Norverapamil in Small Blood Samples From the Rat by High Performance Liquid Chromatography |
Q58268840 | Rapid Quantitation of Verapamil in Plasma by High-Performance Liquid Chromatography |
Q71044450 | Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum |
Q67003135 | Rapid high-pressure liquid chromatographic analysis of verapamil in blood and plasma |
Q74455151 | Simplified reversed-phase HPLC method with spectrophotometric detection for the assay of verapamil in rat plasma |
Q52435676 | Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil. |
Q58180268 | Spectrophotometric Assay of Certain Cardiovascular Drugs Through Charge Transfer Reactions |
Q42532002 | The effects on left ventricular performance of nifedipine and verapamil in exercise-induced angina pectoris |
Q40253273 | Verapamil hydrochloride: pharmacological properties and role in cardiovascular therapeutics |
Q39720756 | Verapamil: a review of its pharmacological properties and therapeutic use. |
Search more.